Cover Image

Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients

Objectives: Oocyte and/or embryo vitrification after controlled ovarian stimulation (COS) represents the most established method of fertility preservation (FP) before cancer treatment. However, traditional COS regimens are associated with supraphysiologic serum estradiol and are therefore not recomm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Charlotte Sonigo (Author), Nathalie Sermondade (Author), Jéremy Calvo (Author), Julie Benard (Author), Christophe Sifer (Author), Michaël Grynberg (Author)
Format:	Book
Published:	Elsevier, 2019-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
by: Imane Lalami, et al.
Published: (2022)

Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications
by: Charlotte Sonigo, et al.
Published: (2019)

Successful in vivo retrieval of oocytes after ovarian stimulation for fertility preservation before oophorectomy by laparotomy for a young patient with ovarian cancer: Case report and review of literature
by: Julie Benard, et al.
Published: (2021)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
by: Haipeng Huang, et al.
Published: (2022)

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
by: Yoo Jin Shim, et al.
Published: (2018)

Maximize the safety and efficacy of fertility preservation by random start/dual ovarian stimulation for early breast cancer patients
by: Shih-Hung Richard Young, et al.
Published: (2023)

Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study
by: Xiaoyi Yang, et al.
Published: (2019)

Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study
by: Batool Hossein Rashidi, et al.
Published: (2014)

Ovarian endometriosis and fertility preservation problem
by: Galina E. Chernukha, et al.
Published: (2021)

Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors
by: Valeria Lombardi Fäh, et al.
Published: (2024)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
by: Emmanuelle Mathieu d'Argent, et al.
Published: (2020)

Fertility preservation in women with breast cancer
by: Shu-Fen Chen, et al.
Published: (2022)

Two cases of polycystic ovary syndrome with onset of severe ovarian hyperstimulation syndrome following controlled ovarian stimulation with aromatase inhibitors for fertility preservation before breast cancer treatment
by: Sugiko Oishi, et al.
Published: (2021)

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
by: Jigal Haas, et al.
Published: (2017)

First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome
by: Justine Hugon-Rodin, et al.
Published: (2017)

A study of controlled ovarian stimulation with clomiphene citrate or letrozole in combination with gonadotropins and IUI in unexplained infertility
by: Madhusmita Hembram, et al.
Published: (2017)

Fertility preservation in pig using ovarian tissues by vitrification method
by: In-Sul Hwang
Published: (2022)

Methods to preserve fertility in patients with serous borderline ovarian tumors
by: Mekan R. Orazov, et al.
Published: (2024)

Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT
by: Maryam Eftekhar, et al.
Published: (2020)

Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation
by: Brunengraber Lisa N, et al.
Published: (2011)

Fertility preservation in patients with breast cancer. Literature review
by: Marina V. Kiseleva, et al.
Published: (2023)

Ovarian stimulation for fertility preservation in a woman with borderline serous ovarian tumor causing a large fluctuating subcutaneous fluid collection: a case report
by: Ranit Hizkiyahu, et al.
Published: (2021)

Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT
by: Mahbod Ebrahimi, et al.
Published: (2017)

Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT
by: Farahnaz Farzaneh, et al.
Published: (2020)

Fertility Preservation for Young Women with Breast Cancer: Review and Perspective
by: Shuxin Zheng, et al.
Published: (2024)

Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
by: Oranite Goldrat, et al.
Published: (2019)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
by: Moran Shapira, et al.
Published: (2020)

Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
by: Ashraf Moini, et al.
Published: (2019)

Second fertility preservation surgery for early relapse of seromucinous borderline ovarian tumors
by: Motoko Kanno, et al.
Published: (2021)

Letrozole and ovarian hyperstimulation syndrome: Retrospective cross-sectional study
by: Elham Nikfarjam, et al.
Published: (2024)

Editorial: Fertility preservation
by: Berna Dilbaz
Published: (2024)

Fertility Preservation in Girls
by: Jennia Michaeli, et al.
Published: (2012)

Preparation and Characterization of Topical Letrozole Nanoemulsion for Breast Cancer
by: Ihab D. Hammodi, et al.
Published: (2020)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
by: Matteo Lambertini, et al.
Published: (2019)

Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo
by: Taichi Akahori, et al.
Published: (2019)

Development of the knowledge of fertility and fertility preservation scale
by: McNees P, et al.
Published: (2012)

Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: Challenges for fertility preservation
by: Agarwal Ashok, et al.
Published: (2008)

Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention?
by: Ying Liang, et al.
Published: (2021)

Fertility Preservation in Gynecological Cancers
by: Shakuntala Chhabra, et al.
Published: (2013)

Fertility preservation for transgender individuals
by: James Barrett
Published: (2022)